Everything You Need to Know about Biofilms

At a Glance:

1. Biofilms are communities of microbes embedded in slimy gel-like substances. The biofilms protect the microbes (bacteria, fungi, parasites, viruses) from the immune system and antimicrobials.
2. Your mouth and gut are a mish-mash of biofilms. Biofilms can also be healthy, neutral, dysbiotic, and pathogenic. Pathogenic biofilms house some disease-causing microbes, which can make them resistant to treatments.
3. Infections can be chronic, treatment resistant, or negative on tests because they’re hidden away in biofilms. These can include Helicobacter pylori, SIBO, Lyme, Candida, gum diseases, chronic wounds, ear infections, urinary tract infections, certain parasites, and more. 
4. Breaking biofilms can release toxic and inflammatory substances, so it’s crucial to take steps to minimize Herxheimer reactions before aggressively attacking biofilms.
5. Biofilms should be taken into consideration when treating or preventing any infections.
6. Ozone gas, water, and oil may break biofilms, as do many natural compounds and herbs. 
7. Biofilm-forming probiotic strains are more likely to colonize in your gut, but colonization depends on many other factors and isn’t necessary to reap benefits from probiotics. 

Biofilms account for 75% of infections, especially chronic and treatment-resistant ones, such as ear and vaginal infections, toenail fungus, certain gut infections, and more. The biofilm materials protect microbes from antimicrobials, making them harder to treat. Also, breaking biofilms can release substances that induce immune responses, causing symptoms. 

Ozone gas, oil, and water can break biofilms, which may explain why it may be more effective than drugs in treatment-resistant cases. Studies have also shown that ozone therapy can increase the effectiveness of drugs or herbal antimicrobials. Ozone therapy helps with infection by:

• Breaking biofilm
• Oxidizing various components of the microbes 
• Stimulating the immune system, especially when it’s stagnant and cannot fight off the infection on its own

This article will cover everything you need to know about biofilms. 

What is Biofilm, and Why Is it Important for Health and Infectious Diseases?

 A familiar example may be slippery green lichens in a waterfall, which has a biofilm of bacteria, algae, and other microorganisms.

Biofilms are complex, structured communities of microorganisms that adhere to surfaces and envelop themselves in a self-produced matrix of gel-like extracellular polymeric substances (EPS) [1].

The biofilm’s protective matrix is made up of polysaccharides, proteins, lipids, and nucleic acids. It forms a slimy and protective barrier around a microbial colony anywhere on your body like mucus membranes and teeth.

How Biofilms Form

Biofilm formation begins when free-floating microorganisms attach to a surface. Once attached, these microbes communicate with each other via communication chemicals. This communication is called quorum sensing, which helps signal population density and coordinate behavior [2]. 

As the biofilm gets stronger, layers of microbes get embedded within the EPS, forming a highly structured and protective microenvironment. These layered communities contain multiple microbial species, all interacting to enhance survival under hostile conditions [2].

Why Biofilms Matter for Health

Biofilms are critical players in health and disease. There are both good and bad biofilms. For example, some of your gut and oral microbiota are in biofilms [3]. The biofilms with good bacteria support numerous aspects of health. 

Biofilms can also be dysbiotic, or imbalanced, but not pathogenic. Dysbiotic biofilms have an imbalance and lower diversity of microbes, making them less resistant to pathogens or stressors. Also, some of these microbes can become pathogenic, for instance secreting inflammatory molecules [4].

Pathogenic (disease-causing) microbes can also form biofilms which make them harder to eradicate. Biofilms formed by harmful bacteria, fungi, parasites, or mixed communities are highly resistant to antibiotics, disinfectants, and immune system attacks. This can create treatment-resistant infectious diseases.

This resistance stems from several factors [5]:

• Physical barrier: The EPS matrix blocks antimicrobial agents from reaching the embedded microbes.
• Metabolic diversity: Some microbes within the biofilm exist in a dormant state, making antibiotics—most of which target actively dividing cells—less effective.
• Gene exchange: Antimicrobial resistant genes can be on a small piece of DNA that can be copied and moved between microbe cells. This is called horizontal gene transfer, which happens more readily inside a biofilm, spreading antibiotic resistant genes.

Biofilms in Infectious Diseases

Pathogenic biofilms are implicated in a wide range of infections, especially stubborn ones, including [6]:

• Chronic sinus infections
• Ear infections
• Urinary tract infections (UTIs)
• Dental plaque and periodontal disease
• Chronic wounds
• Implant- and catheter-associated infections
• Lyme
• Toenail fungus

Because biofilms shield pathogens from the immune system and traditional antibiotics, biofilm infections tend to become persistent, relapsing, and difficult to eradicate. 

This is why addressing biofilms directly has become a growing focus in integrative medicine, wound care, and infection control.

Where Are Biofilms in the Body and How Do They Affect Your Health?

Biofilms can develop on virtually any surface within the human body, especially in areas where moisture, nutrients, and microbial attachment sites are abundant. 

These biofilms can either support health—such as the protective biofilms in the gut and skin—or they can contribute to chronic infections and disease when pathogenic microbes take hold.

Oral Cavity

The oral cavity is one of the most biofilm-dense environments in the human body, so these biofilms are a central player in both oral health and disease progression. These biofilms are not inherently harmful—healthy oral biofilms can protect against pathogens and maintain ecological balance. However, when oral dysbiosis occurs, pathogenic species can overgrow, trigger inflammation, and contribute to gum diseases and tooth decay [7]. Once a pathogenic biofilm forms, it becomes highly resistant to mechanical cleaning, antibiotics, and even some antiseptics. 

Biofilms can form on teeth, gums, tongue, and dental materials (crowns, implants, and dentures). Once they form, they can be notoriously difficult to eliminate, whether with antimicrobials, mechanical methods, or conventional oral hygiene. These biofilms can contribute to tooth decay, gum disease, recurrent oral thrush, and post-procedure complications. Common biofilm-forming oral pathogens include [8]:

• Streptococcus mutans, responsible for dental plaque and cavities. Dental plaque is a classic example of a mature, complex biofilm.
• Porphyromonas gingivalis, responsible for periodontal disease and peri-implantitis.
• Candida albicans, responsible for recurrent oral thrush on the tongue or oral mucosa, especially in immunocompromised patients.

The interplay between oral biofilms and systemic health is a growing area of research, with evidence linking oral biofilm dysbiosis to cardiovascular disease, diabetes, and adverse pregnancy outcomes [9].

Sinuses and Upper Respiratory Tract

Biofilms can take hold in sinus cavities, nasal passages, and upper airways. Common pathogens include [10]:

• Pseudomonas aeruginosa
• Staphylococcus aureus (including MRSA)
• Haemophilus influenzae
• Aspergillus spp. (in fungal sinusitis)

Lungs

These can occur in bronchi and lung tissue (particularly in patients with cystic fibrosis, COPD, or bronchiectasis) in patients with compromised immune systems. Common pathogens include [11]:

• Pseudomonas aeruginosa
• Burkholderia cepacia
• Aspergillus fumigatus
• Staphylococcus aureus

In respiratory diseases, biofilms contribute to chronic airway inflammation and antibiotic resistance, making infections very difficult to clear.

Urinary Tract and Vaginal Canal

Biofilms play an important role in the persistence and recurrence of urogenital infections in the bladder, urethra, and vaginal canal.

Urinary Tract

Escherichia coli (E. coli) is the most common culprit of biofilm-associated urinary tract infections (UTIs). These bacterial biofilms can adhere to the bladder lining (urothelium), creating intracellular bacterial communities that act as reservoirs for recurrent infections. Even after symptoms resolve, biofilm bacteria may lie dormant within the bladder wall, re-emerging when conditions favor their growth [12].

Vaginal and Cervical Areas

Gardnerella vaginalis, a key player in bacterial vaginosis (BV), forms dense biofilms on vaginal lining cells, providing a scaffold for other opportunistic bacteria to colonize. 

This polymicrobial biofilm not only makes BV harder to treat, but it also resists antibiotic treatment and disrupts the protective Lactobacilli population, worsening vaginal dysbiosis [13].

In clinical practice, understanding the biofilm component of urogenital infections can guide treatment approaches, emphasizing:

• Biofilm-disrupting agents, which may include ozone gas.
• Longer, low-dose antimicrobial courses rather than short, high-dose regimens.
• Restoration of healthy microbes (such as Lactobacillus) both in the gut and vagina. These good bacteria also make the environment unfriendly to pathogenic biofilm formation.

Other common pathogens that may form biofilms in the genitourinary tract include [14]:

• Proteus mirabilis
• Klebsiella pneumoniae
• Enterococcus faecalis

Gut and Gut Flora (Large Intestine)

You may think of the gut flora in your large intestine like a microbe soup, but they’re more like a mishmash of various biofilms. Your gut content that may also have free-floating microbes flow over these biofilms. The gut is one of the most biofilm-rich environments in the human body. Everyone has a mix of good and bad biofilms.

Good Biofilms: Protective and Symbiotic

Probiotic species like Lactobacillus reuteri and Bifidobacterium breve can form stable healthy biofilms—if your gut and immune system welcomes them. Most probiotic supplemental bacteria pass through temporarily, delivering health benefits during the 2-3 weeks they’re in your gut. However, biofilm-forming variants are more likely to colonize and stay long-term, although research suggests that your gut and immune system patterns choose which strains stay [15]. 

Functions of healthy biofilms include [16,17]:

• Anchoring probiotics to the gut lining, allowing them to colonize and deliver long-term benefits.
• Producing beneficial metabolites like short-chain fatty acids (SCFAs) that support gut health and reduce inflammation.
• Blocking pathogenic biofilm formation by outcompeting harmful species for space and nutrients. These microbes may also secrete substances that inhibit harmful microbes.

Harmful Biofilms: Drivers of Chronic Dysbiosis

On the flip side, species like Clostridium difficile and Helicobacter pylori are good at forming biofilms that contribute to recurrent infections and chronic gut inflammation [18].

Dysbiotic biofilms can:

• Shield pathogens from immune response, antibiotics, antimicrobials, and probiotics, allowing infections to persist despite treatment.
• Produce inflammatory metabolites that damage the gut lining and disrupt immune tolerance.
• Trap toxins like mycotoxins, heavy metals, and microbial byproducts, further contributing to gut and systemic toxicity.

Small Intestinal Bacterial Overgrowth

Small intestinal bacterial overgrowth (SIBO) is a condition characterized by an excessive growth of bacteria in the small intestine, a part of the digestive tract that should normally have low bacterial counts compared to the colon. 

While SIBO is framed as a matter of microbial imbalance, biofilms play a major—yet overlooked—role in the persistence and recurrence of SIBO [19].

Specific Pathogens Involved

While SIBO is polymicrobial, certain bacteria are more likely to form biofilms and drive treatment-resistant cases:

• Klebsiella spp. – Associated with methane-dominant SIBO and linked to autoimmune flares, particularly in conditions like ankylosing spondylitis.
• Enterococcus spp. – Biofilm-forming enterococci form after antibiotic therapy.
• Proteus spp. – Contribute to both SIBO and urinary tract infections (via gut-bladder migration).
• Escherichia coli – Leads to both hydrogen and methane production, depending on the strain.
• Lactobacilli, when overgrown in the small intestine, can be part of the microbial community in SIBO.

Parasite Infections

When we think of parasite infections, we picture free-moving organisms like Giardia, Blastocystis, or Entamoeba, swimming through the gut.

However, many parasites—especially the microscopic ones—are increasingly being recognized for their ability to form or embed themselves within biofilms in the gastrointestinal tract. 

How Parasites Interact with Biofilms

Unlike bacteria, parasites themselves do not always build the biofilm matrix, but they can colonize existing bacterial biofilms, hiding within these protective environments. 

Some parasites have been found embedded in mixed-species biofilms, living alongside bacteria and even fungi. These multi-organism biofilms create an ideal habitat for parasite persistence.

In some cases, bacterial biofilms produce extracellular polymers that can trap parasite cysts, effectively shielding them from immune surveillance and antimicrobial treatments [20]. 

This can explain why recurrent parasitic infections are so common, even after what appears to be successful treatment. The test can find no parasites today, but detect them again in a few months.

Common Parasites Known to Associate with Biofilms

• Blastocystis hominis – Associated with chronic gut dysbiosis [21].
• Giardia lamblia – Forms cyst stages that can embed in intestinal mucus layers, particularly in biofilm-dense areas [22].
• Cryptosporidium parvum – Usually associated with acute diarrhea, chronic infections in immunocompromised individuals may involve biofilm formation [23].

Clinical Implications

When parasites embed in biofilms, they are much harder to detect and treat. Stool tests that examine the stool for parasites can easily miss them, whereas PCR tests are more likely to detect when they’re present in low numbers [24].

Candida albicans or other fungal infections

Candida albicans is one of the best known fungal organisms capable of forming robust biofilms both in the gut and on mucosal surfaces throughout the body. It explains why they’re so hard to get rid of.

Unlike free-floating yeast cells, Candida cells within a biofilm exist in a protected matrix, which shields them from both immune response and antifungal agents.

Within these biofilms, Candida shifts from its yeast form to its hyphal (tube) form, which enhances its invasiveness and ability to penetrate tissue barriers. 

This form shift also upregulates genes linked to antifungal resistance, making biofilm-associated Candida infections far more difficult to clear than planktonic (free-floating) infections [25].

However, Candida albicans is not the only fungi species capable of forming biofilms. Several other fungi, both commensal and pathogenic, can also form biofilms that contribute to chronic infections and treatment resistance:

• Candida glabrata: Known for its intrinsic antifungal resistance, this species forms dense, resilient biofilms in immunocompromised patients [26].
• Candida parapsilosis: Found on medical devices such as catheters and prosthetic joints [27].
• Candida krusei: This species is  resistant to fluconazole and capable of forming biofilms in both mucosal and bloodstream infections [28].
• Aspergillus fumigatus: Aspergillus forms biofilms in the lungs, particularly in patients with cystic fibrosis or chronic obstructive pulmonary disease (COPD) [29].
• Malassezia species: These lipophilic (fat loving) yeasts are associated with seborrheic dermatitis and fungal acne [30].
• Cryptococcus neoformans: Known for causing meningitis in immunocompromised patients, Cryptococcus can form biofilms in the central nervous system [31].

Biofilm-associated fungal infections require multifaceted treatment strategies, including [32]:

• Biofilm disruptors: enzymes, chelating agents, surfactants, or ozone therapy.
• Combination antifungal therapy targeting both planktonic and biofilm-embedded cells.
• Gut and skin flora reoptimization to reduce fungal overgrowth and restore microbial balance.
• Immune support: nutrients, herbs, ozone therapy.

Medical Implants and Devices

Medical devices, both implanted and external, are very prone to biofilm formation, presenting a challenge in modern healthcare.

Any surface that comes into contact with bodily fluids—whether it’s catheters, prosthetic joints, heart valves, stents, implants, or pacemakers—can potentially become colonized by microorganisms that form biofilms.

Common pathogens include [33]:

• Staphylococcus epidermidis
• Staphylococcus aureus
• Candida albicans
• Pseudomonas aeruginosa

These biofilms can begin forming within hours of device placement, especially in patients with compromised immunity, underlying infections, or prolonged device use [34]. 

The clinical consequences of biofilms on medical devices can be severe, including:

• Chronic low-grade infections that may not resolve even with prolonged antibiotics.
• Device failure, which may require removal and replacement, increasing surgical risk.
• Increased risk of sepsis, especially if biofilm fragments disperse into the bloodstream, causing secondary infections or triggering immune response elsewhere.

Skin and Chronic Wounds

Biofilms can develop on the skin and wound, such as in diabetic ulcers, pressure sores, surgical sites, and burns. Common pathogens include [35]:

• Staphylococcus aureus (including the multi-resistant MRSA)
• Pseudomonas aeruginosa
• Enterococcus spp.
• Candida albicans

What are Biofilm Treatments? 

Biofilm Disruptor Compounds

When addressing chronic infections or persistent dysbiosis, disrupting the biofilm matrix itself is necessary so that antimicrobials, antifungals, or antiparasitics can work effectively. 

A range of compounds—both natural and pharmaceutical—have shown potential for breaking down biofilms. These agents typically work by:

• Chelation (removing essential metals that stabilize the biofilm)
• Enzymatic degradation of the biofilm matrix
• Interference with bacterial communication (quorum sensing)

Herbals and Natural Compounds

• Garlic (allicin) – Inhibits quorum sensing and disrupts biofilm formation in species like Pseudomonas aeruginosa [36].
• Berberine – Effective against both bacterial and fungal biofilms, particularly in the gut [37].
• Oregano oil – Having broad-spectrum antimicrobial properties, oregano oil also breaks down biofilms by disrupting cell membranes and quorum sensing molecules [38].
• Curcumin – Demonstrates anti-biofilm properties against a range of bacteria, including Staphylococcus aureus and Escherichia coli [39].
• Cinnamon oil – Disrupts Candida biofilms [40].

Some drawbacks of natural remedies include:

• Gastrointestinal upset is common, especially with essential oils.
• Herxheimer reactions or temporary worsening of symptoms from microbial die-off. 
• Long-term or high-dose use may disrupt beneficial biofilms and microbiome balance.

Pharmaceutical and Synthetic Agents

• N-acetylcysteine (NAC) – A mucolytic (mucous breaking) agent that can disrupt the polysaccharide matrix in biofilms, making the microbes more susceptible to antibiotics [41]. While generally well-tolerated, side effects may include nausea, diarrhea, or allergic reactions.
• Xylitol – A sugar alcohol, xylitol inhibits biofilm formation, particularly in Streptococcus mutans, making it useful for oral biofilms [42].
• Bismuth thiols – Bismuth compounds combined with thiols (sulfur compounds) are effective against resistant bacterial biofilms, including Helicobacter pylori [43].
• Ethylenediaminetetraacetic acid (EDTA) – A chelating agent that strips essential metals like calcium, magnesium, and iron from biofilms, destabilizing their structure [44]. The side effect of EDTA is that it may deplete essential minerals from the body, especially with prolonged or high-dose use. 
• Lactoferrin – An iron-binding protein that can disrupt iron-dependent biofilms and enhance antibiotic penetration [45]. While generally well-tolerated, lactoferrin can irritate the gut or cause histamine reactions.

Aggressive biofilm disruption can release bacteria and biofilm components that stimulate the immune system, which can lead to die-off symptoms, ranging from fatigue and brain fog to histamine flares or autoimmune exacerbations. Also, combining multiple biofilm disruptors can overwhelm detox pathways, particularly in patients with impaired detoxification.

To avoid Herxheimer reactions, it is first crucial to address the basics like nutrition, sleep, and elimination before attacking the biofilms. Then, start with gentle, staged approaches, often combined with binders, detox support, and gut flora replenishment to be safer and more sustainable for chronically ill patients.

Continuous monitoring of clinical progress and adjusting disruptor protocols to avoid overtreatment is essential in biofilm-targeting therapies.

Ozone Gas

Ozone gas is emerging as a highly versatile tool for disrupting biofilms in a wide range of clinical and environmental contexts. 

Unlike some conventional biofilm disruptors, ozone gas works rapidly, penetrating deep into biofilms and reaching embedded bacteria, fungi, and parasites that are otherwise resistant to antimicrobials [46].

Mechanism of Action – Biofilm Disruption

When ozone gas is applied to a biofilm, it initiates oxidative stress, targeting key molecular bonds within the EPS [47]. By oxidizing and denaturing lipids and polysaccharides, ozone directly destabilizes biofilm architecture. This exposes the microbes to the immune system and therapeutic agents.

Ozone also modifies quorum sensing, the microbial communication system that governs biofilm formation and maturation [48]. By disrupting these signaling pathways, ozone gas can inhibit new biofilm formation in addition to breaking down established colonies.

Ozone ear insufflation can help treat ear and sinus infections. 

‍

Oral and Dental Applications

An in situ clinical study evaluated the effectiveness of gaseous ozone alone and in combination with chlorhexidine (CHX) and fluoride on the formation of oral biofilm in 10 pediatric patients [49].

Each child wore a removable maxillary plate containing bovine tooth sections for 6, 24, and 48 hours to allow biofilm formation. Plaque thickness and viable bacterial percentages were evaluated using confocal laser scanning microscopy at all three time intervals.

Results showed that:

• All treatments reduced plaque formation and viable bacteria percentages compared to the control group (saline).
• At 48 hours, ozone + CHX and ozone + fluoride performed best in the caries-free group.
• Ozone + CHX consistently showed the strongest inhibitory effect on bacterial growth at all time intervals (P < 0.05).

This study reinforces ozone’s potential role in pediatric dentistry, especially for patients who may be sensitive to conventional chemical antimicrobials.

‍

Medical Devices

Ozone gas can be used to sterilize indwelling medical devices, at high risk of biofilm colonization such as catheters, implants, and prosthetics. However, it’s important to ensure that these materials are ozone resistant, or that the concentration of ozone used does not degrade the materials [50].

Ozone oil

Ozone oil offers a unique and versatile approach to biofilm disruption, particularly in topical and mucosal applications. 

Created by bubbling pure ozone gas through plant-based oils (most commonly olive, sunflower, hemp, or castor oil), ozone oil contains a rich mixture of ozonides and peroxides—molecules that retain ozone’s oxidative power in a stable, slow-release format [51]. 

These ozonides make ozone oil far gentler than direct ozone gas. It can be applied topically, intravaginally, rectally, in the mouth, or taken orally for upper gut infections. Breathing ozone oil may also help with sinus and lung biofilms.

Mechanism of Action

Ozone oil disrupts biofilms through oxidative damage, much like ozone gas, but with the added benefit of longer contact time on surfaces.

Ozonides modulates local inflammation, which may help prevent reactive biofilm formation in response to tissue injury or infection [52].

By reducing inflammation, ozone oil can also help restore healthy epithelial barriers, which further discourages pathogenic biofilm development.

Skin and Wound Biofilms

Ozone oil has been widely used in wound care, where biofilm-heavy infections often delay healing. The oil base delivers a sustained dose of ozonides, ensuring extended antimicrobial action.

An in vitro study evaluated the efficacy of ozonated olive oil against Leishmania major, the causative agent of cutaneous leishmaniasis [53]. 

L. major promastigotes were cultivated and incubated with varying concentrations of ozonated olive oil (0, 0.626, 0.938, 1.25, 2.5, 5, and 10 mcg/ml) at 28°C for 24 hours. The results were compared against Glucantime (a common antimonial drug) and non-ozonated olive oil.

Results showed that:

• Ozonated olive oil significantly reduced L. major promastigote survival compared to non-ozonated olive oil (p < 0.001).
• The IC50 (the concentration required to inhibit parasite growth by 50%) for ozonated olive oil was 0.002 mg/ml, whereas Glucantime required a much higher concentration of 165 mg/ml.
• The effect was dose-dependent, with higher concentrations of ozonated olive oil showing greater efficacy.

Given its potential effectiveness, low cost, and ease of use, ozonated olive oil could be explored as an alternative or adjunct therapy for cutaneous leishmaniasis, though further in vivo studies and clinical trials are necessary to validate its therapeutic potential.

Oral Biofilms and Dental Plaque

A test tube study investigated the formation and treatment of bacterial, fungal, and mixed-species biofilms composed of Candida species and Streptococcus mutans [54]. 

The researchers explored how these biofilms develop under both aerobic and microaerobic conditions and evaluated the antimicrobial effect of ozonated sunflower oil.

Results showed that:

• All tested microorganisms were capable of forming biofilms regardless of the ozonation levels.
• Treatment with ozonated sunflower oil, applied for durations ranging from 5 to 120 minutes, significantly reduced the viability of all biofilms, whether bacterial, fungal, or interkingdom.
• Microscopy confirmed the structural disruption of biofilms following treatment.

Ozonated sunflower oil exhibited potent antimicrobial effects against single and mixed-species biofilms associated with oral infections, offering a promising therapeutic option for managing oral diseases.

Compared to ozone gas, ozone oil lasts longer, is more versatile, and tends to be more gentle on sensitive tissues. The ozonides can also penetrate the skin barriers, which may help with deeper infections. Both ozone oil and gas have broad-spectrum efficacy against bacteria, fungi, and parasites.

However, if the starting oil was impure or ozonated with impure ozone gas, the ozonated oils may contain harmful byproducts or fail to retain sufficient ozonides.

Ozone water

Ozone water, created by dissolving ozone gas into purified water, offers another effective tool for biofilm disruption, especially for surfaces, mucosal tissues, and hard-to-reach areas such as dental crevices or surgical sites. 

Unlike ozone oil, which slowly releases ozonides over time, ozone water delivers a quick burst of oxidative power, ideal for short-term antimicrobial applications.

Oral Biofilms and Dental Plaque

Ozone water has been widely studied in dentistry, where it’s used for rinses, irrigation, and disinfection.

An in vitro study evaluated the antimicrobial efficacy of 2.5% sodium hypochlorite (NaOCl) and 8 µg/mL ozonated water, both applied with passive ultrasonic irrigation, in disinfecting root canals infected with mature multispecies biofilms. The biofilms consisted of Enterococcus faecalis, Candida albicans, and Staphylococcus aureus [55].

105 oval-shaped mandibular premolars were instrumented, sterilized, and inoculated with the biofilm. Microbial sampling occurred before or after disinfection.

Results showed that:

• Significant microbial reduction was observed in the ozone and sodium hypochlorite groups (p < 0.05).
• The ozone group achieved complete elimination of microorganisms (counts reduced to zero), demonstrating superior efficacy (p < 0.05).

Ozonated water, while effective, benefited significantly from mechanical agitation, demonstrating its potential as an adjunctive disinfectant.

Sinus and Nasal Applications

Ozone water can also be used in nasal rinses, where it penetrates biofilms linked to chronic sinus infections (sinusitis).

Nasal biofilms, often formed by Staphylococcus aureus and Pseudomonas aeruginosa, are particularly resistant to antibiotics, making ozone water rinse an attractive alternative.

Wound Care and Skin Biofilms

In wound care, ozone water has been used to irrigate chronic wounds, diabetic ulcers, and surgical sites. 

By breaking apart biofilm structures formed by pathogens like MRSA or Pseudomonas, ozone water can help improve wound healing outcomes.

Gastrointestinal Issues

A clinical study evaluated the effectiveness of a combination therapy using ozonated water (oral intake) and rectal insufflation with an oxygen-ozone mixture in the treatment of intestinal dysbiosis [56]. 

For 90 days, 34 patients with intestinal dysbiosis drank three 125 mL glasses of ozonated water per day. Rectal insufflation was administered 3 times per week at 40 µg/mL. 

Results showed:

• Significant symptom improvement was observed across the 90 days in:
  
  • Constipation
  • Bloating 
  • Abdominal pain
  • Chronic fatigue
  • Halitosis (bad breath)
• Biomarker improvement:
  
  • Indican and skatole levels (markers of gut dysbiosis) were reduced, indicating a shift toward healthier gut flora.

The combined use of ozonated water and rectal ozone insufflation significantly improved both subjective symptoms and objective biomarkers in patients with intestinal dysbiosis with no reported adverse effects.

In some cases, ozonated oils are taken orally to help disrupt intestinal biofilms linked to chronic infections such as SIBO, Candida overgrowth, and parasitic infections. 

Ozone water has several advantages in treating biofilms, including:

• Immediately disrupts biofilms
• Leaves no chemicals or byproducts behind
• Can penetrate into crevices and hard-to-reach surfaces, especially with pressurized irrigation

However, certain drawbacks exist with ozone water:

• Short-lived potency – ozone water loses its oxidative strength within 15 minutes to hours, requiring fresh preparation for each application.
• No sustained action – unlike ozone oil, ozone water does not provide a prolonged antimicrobial effect, meaning repeated applications may be necessary for stubborn biofilms.
• Tissue irritation risk
• Limited penetration in deep tissues – ozone water works best on surface biofilms.

Conclusion

If you struggle with infectious diseases or want to optimize your health, it’s a good idea to learn about biofilms so you can take them into account in your treatment protocols. Biofilms can make infections undetectable or very difficult to treat, so it’s crucial to break them during the treatment. However, aggressively breaking biofilms before your body is ready can create worse Herxheimer reactions. Also, ozone gas, water, and oil can break biofilms, which may explain why they can cause Herxheimer reactions. Therefore, we recommend working with a trained practitioner to personalize your ozone therapy and antimicrobial protocols.

‍

References

1 López, D., Vlamakis, H. and Kolter, R. (2010) Biofilms. Cold Spring Harb Perspect Biol 2, a000398 

2 Rather, M. A., Gupta, K. and Mandal, M. (2021) Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies. Braz J Microbiol 52, 1701–1718 

3 Sánchez, M. C., Velapatiño, A., Llama-Palacios, A., Valdés, A., Cifuentes, A., Ciudad, M. J., et al. (2022) Metataxonomic and metabolomic evidence of biofilm homeostasis disruption related to caries: An in vitro study. Mol Oral Microbiol 37, 81–96 

4 Herrero, E. R., Fernandes, S., Verspecht, T., Ugarte-Berzal, E., Boon, N., Proost, P., et al. (2018) Dysbiotic biofilms deregulate the periodontal inflammatory response. Journal of Dental Research, SAGE PublicationsSage CA: Los Angeles, CA 

5 Mirghani, R., Saba, T., Khaliq, H., Mitchell, J., Do, L., Chambi, L., et al. (2022) Biofilms: Formation, drug resistance and alternatives to conventional approaches. AIMS Microbiol 8, 239–277 

6 Zhao, A., Sun, J. and Liu, Y. (2023) Understanding bacterial biofilms: From definition to treatment strategies. Front Cell Infect Microbiol 13, 1137947 

7 Maier, T. (2023) Oral microbiome in health and disease: Maintaining a healthy, balanced ecosystem and reversing dysbiosis. Microorganisms 11 

8 Bertolini, M., Costa, R. C., Barão, V. A. R., Cunha Villar, C., Retamal-Valdes, B., Feres, M., et al. (2022) Oral microorganisms and biofilms: New insights to defeat the main etiologic factor of oral diseases. Microorganisms 10 

9 Berger, D., Rakhamimova, A., Pollack, A. and Loewy, Z. (2018) Oral biofilms: Development, control, and analysis. High Throughput 7 

10 Fastenberg, J. H., Hsueh, W. D., Mustafa, A., Akbar, N. A. and Abuzeid, W. M. (2016) Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies. World J Otorhinolaryngol Head Neck Surg 2, 219–229 

11 Boisvert, A.-A., Cheng, M. P., Sheppard, D. C. and Nguyen, D. (2016) Microbial biofilms in pulmonary and critical care diseases. Ann Am Thorac Soc 13, 1615–1623 

12 Ramírez Castillo, F. Y., Guerrero Barrera, A. L., Harel, J., Avelar González, F. J., Vogeleer, P., Arreola Guerra, J. M., et al. (2023) Biofilm formation by Escherichia coli isolated from urinary tract infections from Aguascalientes, Mexico. Microorganisms 11 

13 Ma, X., Wang, X., Ye, S., Liu, J., Yuan, H. and Wang, N. (2022) Biofilm and pathogenic factor analysis of Gardnerella vaginalis associated with bacterial vaginosis in Northeast China. Front Microbiol 13, 1033040 

14 Lila, A. S. A., Rajab, A. A. H., Abdallah, M. H., Rizvi, S. M. D., Moin, A., Khafagy, E.-S., et al. (2023) Biofilm lifestyle in recurrent urinary tract infections. Life (Basel) 13 

15 Zmora , N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., et al. (2018) Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell, Cell Press 174, 1388–1405.e21 

16 Yao, P., Mohd Esah, E. and Zhao, C. (2024) Regulatory mechanisms and applications of Lactobacillus biofilms in the food industry. Front Microbiol 15, 1465373 

17 Kelly, S. M., Lanigan, N., O’Neill, I. J., Bottacini, F., Lugli, G. A., Viappiani, A., et al. (2020) Bifidobacterial biofilm formation is a multifactorial adaptive phenomenon in response to bile exposure. Scientific Reports, Nature Publishing Group 10, 1–14 

18 Buret, A. G., Motta, J.-P., Allain, T., Ferraz, J. and Wallace, J. L. (2019) Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases: a role for iron? J Biomed Sci 26, 1 

19 Jandl, B., Dighe, S., Gasche, C., Makristathis, A. and Muttenthaler, M. (2024) Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities. Clin Microbiol Rev 37, e0013323 

20 Zanditenas, E. and Ankri, S. (2024) Unraveling the interplay between unicellular parasites and bacterial biofilms: Implications for disease persistence and antibiotic resistance. Virulence 15, 2289775 

21 Lepczyńska, M., Białkowska, J., Dzika, E., Piskorz-Ogórek, K. and Korycińska, J. (2017) Blastocystis: how do specific diets and human gut microbiota affect its development and pathogenicity? Eur J Clin Microbiol Infect Dis 36, 1531–1540 

22 Beatty, J. K., Akierman, S. V., Motta, J.-P., Muise, S., Workentine, M. L., Harrison, J. J., et al. (2017) Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms. Int J Parasitol 47, 311–326 

23 Lefebvre, M., Razakandrainibe, R., Villena, I., Favennec, L. and Costa, D. (2021) Cryptosporidium-Biofilm interactions: A review. Appl Environ Microbiol 87 

24 Stensvold, C. R. and Nielsen, H. V. (2012) Comparison of microscopy and PCR for detection of intestinal parasites in Danish patients supports an incentive for molecular screening platforms. J Clin Microbiol 50, 540–541 

25 Gulati, M. and Nobile, C. J. (2016) Candida albicans biofilms: development, regulation, and molecular mechanisms. Microbes Infect 18, 310–321 

26 Rodrigues, C. F., Rodrigues, M. E., Silva, S. and Henriques, M. (2017) Candida glabrata biofilms: How far have we come? J Fungi (Basel) 3 

27 Pannanusorn, S., Ramírez-Zavala, B., Lünsdorf, H., Agerberth, B., Morschhäuser, J. and Römling, U. (2014) Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis. Eukaryot Cell 13, 438–451 

28 Malinovská, Z., Čonková, E. and Váczi, P. (2023) Biofilm formation in medically important Candida species. J Fungi (Basel) 9 

29 Morelli, K. A., Kerkaert, J. D. and Cramer, R. A. (2021) Aspergillus fumigatus biofilms: Toward understanding how growth as a multicellular network increases antifungal resistance and disease progression. PLoS Pathog 17, e1009794 

30 Čonková, E., Proškovcová, M., Váczi, P. and Malinovská, Z. (2022) In vitro biofilm formation by Malassezia pachydermatis isolates and its susceptibility to azole antifungals. J Fungi (Basel) 8 

31 Martinez, L. R. and Casadevall, A. (2015) Biofilm formation by cryptococcus neoformans. Microbiol Spectr 3 

32 Roy, R., Tiwari, M., Donelli, G. and Tiwari, V. (2018) Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence 9, 522–554 

33 Donlan, R. M. (2001). Biofilms and Device-Associated Infections. Emerging Infectious Diseases, 7 (2), 277-281. 

34 Mishra, A., Aggarwal, A. and Khan, F. (2024) Medical device-associated infections caused by biofilm-forming microbial pathogens and controlling strategies. Antibiotics (Basel) 13 

35 Brandwein, M., Steinberg, D. and Meshner, S. (2016) Microbial biofilms and the human skin microbiome. npj Biofilms and Microbiomes, Nature Publishing Group 2, 1–6 

36 Mohsenipour, Z. and Hassanshahian, M. (2015) The effects of allium sativum extracts on biofilm formation and activities of six pathogenic bacteria. Jundishapur J Microbiol 8, e18971 

37 Zhou, Y., Liu, Z., Wen, J., Zhou, Y. and Lin, H. (2023) The inhibitory effect of berberine chloride hydrate on Streptococcus mutans biofilm formation at different pH values. Microbiology Spectrum, American Society for Microbiology 11: e02170-23 

38 Ong, J., Godfrey, R., Isaacson, B., Pasquina, P. and Williams, D. (2022) Determining the antibiofilm efficacy of oregano gel in an ex vivo model of percutaneous osseointegrated implants. Microorganisms 10 

39 Di Salle, A., Viscusi, G., Di Cristo, F., Valentino, A., Gorrasi, G., Lamberti, E., et al. (2021) Antimicrobial and antibiofilm activity of curcumin-loaded electrospun nanofibers for the prevention of the biofilm-associated infections. Molecules 26 

40 Jeong, Y.-J., Kim, H.-E., Han, S.-J. and Choi, J.-S. (2021) Antibacterial and antibiofilm activities of cinnamon essential oil nanoemulsion against multi-species oral biofilms. Scientific Reports, Nature Publishing Group 11, 1–8 

41 Dinicola, S., De Grazia, S., Carlomagno, G. and Pintucci, J. P. (2014) N-acetylcysteine as powerful molecule to destroy bacterial biofilms. A systematic review. Eur Rev Med Pharmacol Sci 18, 2942–2948

42 Loimaranta, V., Mazurel, D., Deng, D. and Söderling, E. (2020) Xylitol and erythritol inhibit real-time biofilm formation of Streptococcus mutans. BMC Microbiol 20, 184 

43 Varposhti, M., Abdi Ali, A. and Mohammadi, P. (2014) Synergistic effects of bismuth thiols and various antibiotics against pseudomonas aeruginosa biofilm. Jundishapur J Microbiol 7, e9142 

44 Finnegan, S. and Percival, S. L. (2015) EDTA: An antimicrobial and antibiofilm agent for use in wound care. Adv Wound Care (New Rochelle) 4, 415–421 

45 Ammons, M. C. and Copié, V. (2013) Lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling 29, 443–455 

46 Smith, N. L., Wilson, A. L., Gandhi, J., Vatsia, S. and Khan, S. A. (2017) Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med. Gas Res. 7, 212–219 

47 Sagai, M. and Bocci, V. (2011) Mechanisms of action involved in ozone therapy: Is healing induced via a mild oxidative stress? Med. Gas Res., Springer Nature 1, 29 

48 Liu, Y., Zhou, H., Wang, J., Liu, S., Xie, G.-J., Liu, B.-F., et al. (2024) Regulatory mechanisms of quorum sensing system of bacteria in response to chlorine and ozone disinfection. Environ Sci Technol 

49 Namazoğlu, B., Aksoy, M., Memiş-Özgül, B. and Tulga-Öz, F. (2023) Anti-microbial efficiency of gaseous ozone’s combined use with fluoride and chlorhexidine on time-related oral biofilm: an in situ study on pediatric patients. Med Gas Res 13, 192–197 

50 Morosavljević, I., Kozak, D., Kosor, T., Morosavljević, J., Ferlič, L. and Gubeljak, N. (2024) The effects of ozone sterilization on the chemical and mechanical properties of 3D-printed biocompatible PMMA. Micromachines (Basel) 15 

51 Travagli, V., Zanardi, I., Valacchi, G. and Bocci, V. (2010) Ozone and ozonated oils in skin diseases: a review. Mediators Inflamm 2010, 610418 

52 Serra, M. E. G., Baeza-Noci, J., Mendes Abdala, C. V., Luvisotto, M. M., Bertol, C. D. and Anzolin, A. P. (2022) The role of ozone treatment as integrative medicine. An evidence and gap map. Front. Public Health, Frontiers Media SA 10, 1112296 

53 Rajabi, O., Sazgarnia, A., Abbasi, F. and Layegh, P. (2015) The activity of ozonated olive oil against Leishmania major promastigotes. Iran J Basic Med Sci 18, 915–919

54 Higa, B., Cintra, B. S., Álvarez, C. M., Ribeiro, A. B., Ferreira, J. C., Tavares, D. C., et al. (2022) Ozonated oil is effective at killing Candida species and Streptococcus mutans biofilm-derived cells under aerobic and microaerobic conditions. Med Mycol 60 

55 Merçon, I. R., Campos, F. U. F. de, Fontana, C. E., Pelegrine, R. A., Martin, A. S. D. and Bueno, C. E. da S. (2023) Analysis of antimicrobial efficacy of sodium hypochlorite and ozonated water against biofilm in oval canals. Braz Dent J 34, 33–41 

56 Loprete, F. and Vaiano, F. (2017) The use of ozonated water and rectal insufflation in patients with intestinal dysbiosis. Ozone Therapy 

‍